Fractionated stereotactic radiotherapy as a primary therapy for cerebral arteriovenous malformation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, J. | - |
dc.contributor.author | Kim, W. C. | - |
dc.contributor.author | Kim, H. J. | - |
dc.contributor.author | Park, H. S. | - |
dc.date.accessioned | 2024-07-08T08:00:26Z | - |
dc.date.available | 2024-07-08T08:00:26Z | - |
dc.date.issued | 2023-05 | - |
dc.identifier.issn | 0167-8140 | - |
dc.identifier.issn | 1879-0887 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/91918 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ELSEVIER IRELAND LTD | - |
dc.title | Fractionated stereotactic radiotherapy as a primary therapy for cerebral arteriovenous malformation | - |
dc.type | Article | - |
dc.identifier.wosid | 001043659002211 | - |
dc.identifier.bibliographicCitation | RADIOTHERAPY AND ONCOLOGY, v.182, pp S927 - S927 | - |
dc.description.isOpenAccess | N | - |
dc.citation.endPage | S927 | - |
dc.citation.startPage | S927 | - |
dc.citation.title | RADIOTHERAPY AND ONCOLOGY | - |
dc.citation.volume | 182 | - |
dc.type.docType | Meeting Abstract | - |
dc.publisher.location | Ireland | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.